Aytu Biopharma (AYTU) Current Deferred Tax Assets (2015)

Aytu Biopharma (AYTU) reported Current Deferred Tax Assets of $94211.0 for Q3 2015, up 127.41% quarter-over-quarter from $41427.0 in Q2 2015.

Aytu Biopharma (AYTU) Current Deferred Tax Assets (2015) Analysis & Trends

Aytu Biopharma (AYTU) has 1 years of Current Deferred Tax Assets data on file, last reported at $94211.0 in Q3 2015.

Current Deferred Tax Assets for Q3 2015 came in at $94211.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2015 was $94211.0 (changed N/A YoY), and the FY2015 annual result was $41427.0, up 119.23% from the prior year.
Current Deferred Tax Assets climbed to $94211.0 in Q3 2015 per AYTU's latest filing, from $41427.0 in the prior quarter.
Over five years, Current Deferred Tax Assets peaked at $94211.0 in Q3 2015 and troughed at $41427.0 in Q2 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	Aytu Biopharma	24.60 Mn	-2.12 Mn	7.60 Mn

Download Data